Bill Summary for S 206 (2023-2024)
Mar 15 2023
|View NCGA Bill Details||2023-2024 Session|
AN ACT TO AMEND THE NORTH CAROLINA CONTROLLED SUBSTANCES ACT TO ESTABLISH NEW VIOLATIONS INVOLVING COUNTERFEIT CONTROLLED SUBSTANCES AND CONTROLLED SUBSTANCES; TO EXPAND THE STATE'S DEFINITION OF OPIOID ANTAGONIST TO INCLUDE ALL OPIOID ANTAGONISTS APPROVED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION FOR THE TREATMENT OF A DRUG OVERDOSE; AND TO ALLOW THE USE OF ALL SUCH FEDERAL FOOD AND DRUG-APPROVED OPIOID ANTAGONISTS IN NEEDLE AND HYPODERMIC SYRINGE EXCHANGE PROGRAMS; TO CONTINUE TO AUTHORIZE PHARMACISTS, PHARMACY INTERNS, AND PHARMACY TECHNICIANS TO ADMINISTER VACCINATIONS AND IMMUNIZATIONS IN RESPONSE TO THE EXPIRING PUBLIC READINESS AND PREPAREDNESS ACT; AND TO CONTINUE THE ACUTE HOSPITAL CARE AT HOME PROGRAM.Intro. by McInnis.
|View: All Summaries for Bill||Tracking:|
Senate committee substitute to the 1st edition makes the following changes. Amends GS 90-108(12a) and (12b) to create exemptions to the prohibition on possessing, manufacturing, distributing, exporting, or importing the enumerated drug making materials with the intention, knowledge, or having reasonable cause to believe that the materials will be used to make a controlled substance to exempt a pharmacy, a pharmacist, a pharmacy technician, or a pharmacy intern licensed or permitted under Article 4A of Chapter 90 of the General Statutes engaging in activities related to the production or delivery of a controlled substance pursuant to a prescription.